Immunomodulation: other approaches.
D000818:Animals; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006082:Graft Enhancement, Immunologic / Q000379:methods*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051379:Mice; D009103:Multiple Sclerosis / Q000628:therapy; D010920:Placenta / Q000276:immunology; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D014181:Transplantation Immunology
D007166:Immunosuppressive Agents; D010972:Platelet Activating Factor; D003630:Daunorubicin